TrialHematological oncology2021

Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.

Barbora Weinbergerova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.